Form 4: Guardant Health CPO's Stock Holdings Update

Guardant Health's Chief People Officer, Terilyn J. Monroe, reported the vesting of restricted stock units and subsequent tax-related share withholding.

Summary

• Terilyn J. Monroe, Chief People Officer of Guardant Health, Inc. (GH), reported changes in her beneficial ownership of company stock.
• On October 1, 2025, 10,477 restricted stock units (RSUs) vested, converting into an equal number of common shares.
• These RSUs were part of an award granted on November 8, 2024, with 33% vesting on this date and the remainder vesting quarterly over the next two years.
• To cover tax withholding obligations related to the RSU vesting, 5,310 shares of common stock were disposed of by the company at a price of $62.65 per share.
• Following these transactions, Monroe's direct beneficial ownership of common stock is 26,087 shares.
• Her direct beneficial ownership of unvested restricted stock units is 21,274 units.
• The filing also noted the acquisition of 663 shares under Guardant Health's Employee Stock Purchase Plan on May 14, 2025.

Sentiment

Score: 7

Explanation: The filing reports routine executive compensation events (RSU vesting and tax withholding) and an ESPP acquisition. These are standard operational activities and do not indicate significant positive or negative news for the company's fundamental performance, but rather reflect ongoing executive alignment.

Positives

• Vesting of 10,477 restricted stock units indicates continued compensation and retention of a key executive.
• The executive's continued beneficial ownership of 26,087 common shares and 21,274 unvested RSUs aligns her interests with shareholders.

Negatives

• Disposition of 5,310 shares for tax withholding reduces the executive's direct common stock holdings.

Future Outlook

The remaining 67% of the restricted stock unit award granted on November 8, 2024, will vest in equal quarterly installments over the two-year period following October 1, 2025.

Industry Context

This Form 4 filing reflects routine executive compensation practices common across publicly traded companies, where restricted stock units are a standard component of long-term incentive plans designed to align executive interests with shareholder value creation. The tax withholding transaction is also a standard procedure upon RSU vesting.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a component of executive compensation is a widely adopted practice across various industries, including biotechnology and healthcare, similar to companies like Illumina (ILMN) or Exact Sciences (EXAS).
• The vesting schedule (33% after one year, then quarterly over two years) is a common structure designed for executive retention and performance alignment.
• The tax withholding mechanism is standard for equity compensation, ensuring compliance with tax obligations upon vesting, consistent with practices observed in most U.S. public companies.

Stakeholder Impact

• Shareholders: The vesting and subsequent tax-related sale of shares by a Chief People Officer indicates continued executive alignment with shareholder interests through equity ownership.
• Employees: The mention of an Employee Stock Purchase Plan (ESPP) suggests broader employee equity participation programs are in place.

Next Steps

• Remaining 67% of the restricted stock units will vest in equal quarterly installments over the next two years.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation events (RSU vesting and tax withholding) and an ESPP acquisition. These transactions are standard and do not provide new material information that would fundamentally alter the investment thesis for Guardant Health. Therefore, a 'hold' recommendation is appropriate as the filing does not present a catalyst for a a significant change in stock valuation, either positive or negative.

Keywords

Guardant Health, GH, SEC Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Executive Compensation, Stock Ownership, Terilyn J. Monroe, Chief People Officer